Interference of Peritoneal Dialysis Fluids with Cell Cycle Mechanisms

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Peritoneal Dialysis International

• Publication date

  2015-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3747/pdi.2013.00010PMID 25082841PMCID PMC4443985
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of the dialysis fluid buffer on peritoneal membrane function in children.

  2013cited by this paper
• Aurora A kinase (AURKA) in normal and pathological cell division

  2013cited by this paper
• The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: the balANZ trial

  2012cited by this paper
• Chemical Genetics Reveals a Specific Requirement for Cdk2 Activity in the DNA Damage Response and Identifies Nbs1 as a Cdk2 Substrate in Human Cells

  2012cited by this paper
• A New Neutral-pH Low-GDP Peritoneal Dialysis Fluid

  2012cited by this paper
• Buffer-dependent regulation of aquaporin-1 expression and function in human peritoneal mesothelial cells

  2012cited by this paper
• Quantification of the six major α-dicarbonyl contaminants in peritoneal dialysis fluids by UHPLC/DAD/MSMS

  2011cited by this paper
• Low-GDP peritoneal dialysis fluid ('balance') has less impact in vitro and ex vivo on epithelial-to-mesenchymal transition (EMT) of mesothelial cells than a standard fluid.

  2011cited by this paper
• Signalling by amino acid nutrients.

  2011cited by this paper
• 3-Deoxygalactosone, a new glucose degradation product in peritoneal dialysis fluids: Identification, quantification by HPLC/DAD/MSMS and its pathway of formation

  2011cited by this paper
• Slouching towards Bethlehem: the beast of biocompatibility.

  2010cited by this paper
• Three-step model for condensin activation during mitotic chromosome condensation

  2010influential reference
• Beta-alanine as a small molecule neurotransmitter.

  2010cited by this paper
• Roles of glutamine in neurotransmission.

  2010cited by this paper
• Development and validation of an HPLC method to quantify 3,4-dideoxyglucosone-3-ene in peritoneal dialysis fluids.

  2009cited by this paper
• Biocompatibility of a bicarbonate-buffered amino-acid-based solution for peritoneal dialysis

  2008cited by this paper
• Glucose-Induced Mesothelial Cell Senescence and Peritoneal Neoangiogenesis and Fibrosis

  2008cited by this paper
• Effects of bicarbonate-containing versus lactate-containing peritoneal dialysis solutions on superoxide production by human neutrophils.

  2008cited by this paper
• 3,4-Dideoxyglucosone-3-ene as a mediator of peritoneal demesothelization.

  2008cited by this paper
• Mesothelial RAGE activation by AGEs enhances VEGF release and potentiates capillary tube formation.

  2007cited by this paper
• Studying the Effects of New Peritoneal Dialysis Solutions on the Peritoneum

  2007cited by this paper
• How to Avoid Glucose Degradation Products in Peritoneal Dialysis Fluids

  2006cited by this paper
• Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation products--a 1-year randomized control trial.

  2006cited by this paper
• Epithelial-to-mesenchymal transition of the mesothelial cell--its role in the response of the peritoneum to dialysis.

  2006cited by this paper
• Changing prescribing practice in CAPD patients in Korea: increased utilization of low GDP solutions improves patient outcome.

  2006cited by this paper
• Effects of New Peritoneal Dialysis Solutions on Leukocyte Recruitment in the Rat Peritoneal Membrane

  2005cited by this paper
• Functional analysis of human microtubule-based motor proteins, the kinesins and dyneins, in mitosis/cytokinesis using RNA interference.

  2005cited by this paper
• Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities

  2005cited by this paper
• Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane.

  2004cited by this paper
• Preprocessing of oligonucleotide array data

  2004cited by this paper
• Reactive oxygen species amplify protein kinase C signaling in high glucose-induced fibronectin expression by human peritoneal mesothelial cells.

  2004cited by this paper
• The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane.

  2004cited by this paper
• Amino Acid-Based Peritoneal Dialysis Solution Stimulates Mesothelial Nitric Oxide Production

  2004cited by this paper
• BIOKID: Randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991]

  2004cited by this paper
• Glucose degradation products increase apoptosis of human mesothelial cells.

  2003cited by this paper
• Improved acidosis correction and recovery of mesothelial cell mass with neutral-pH bicarbonate dialysis solution among children undergoing automated peritoneal dialysis.

  2003cited by this paper
• Viability of, and basic fibroblast growth factor secretion by, human peritoneal mesothelial cells cultured with various components of peritoneal dialysis fluid.

  2003cited by this paper
• Glucose degradation products (GDP) retard remesothelialization independently of D-glucose concentration.

  2003cited by this paper
• Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells.

  2003cited by this paper
• 3,4-Dideoxyglucosone-3-ene (3,4-DGE): a cytotoxic glucose degradation product in fluids for peritoneal dialysis.

  2002cited by this paper
• Morphologic changes in the peritoneal membrane of patients with renal disease.

  2002cited by this paper
• Effects of Peritoneal Dialysis Solutions on the Secretion of Growth Factors and Extracellular Matrix Proteins by Human Peritoneal Mesothelial Cells

  2002cited by this paper
• Regulation of the G2/M transition by p53

  2001influential reference
• Peritoneal dialysis fluids with a physiologic pH based on either lactate or bicarbonate buffer-effects on human mesothelial cells.

  2001cited by this paper
• Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis.

  2001cited by this paper
• Prolonged exposure to glucose degradation products impairs viability and function of human peritoneal mesothelial cells.

  2001cited by this paper
• Dialysate Cancer Antigen 125 Concentration as Marker of Peritoneal Membrane Status in Patients Treated with Chronic Peritoneal Dialysis

  2001cited by this paper
• Effect of dwell time on carbonyl stress using icodextrin and amino acid peritoneal dialysis fluids.

  2000cited by this paper
• Surfing the p53 network

  2000cited by this paper
• Icodextrin Effluent Leads to a Greater Proliferation than Glucose Effluent of Human Mesothelial Cells Studied Ex Vivo

  2000cited by this paper
• Amino acid regulation of gene expression.

  2000cited by this paper
• Effect of glucose degradation products on human peritoneal mesothelial cell function.

  2000cited by this paper
• High Glucose Induces a Hypertrophic, Senescent Mesothelial Cell Phenotype after Long in vivo Exposure

  1999cited by this paper
• Amino acid regulation of gene expression.

  1999cited by this paper
• Glucose degradation product methylglyoxal enhances the production of vascular endothelial growth factor in peritoneal cells: role in the functional and morphological alterations of peritoneal membranes in peritoneal dialysis

  1999cited by this paper
• Current Practice of Peritoneal Dialysis in Children: Results of a Longitudinal Survey

  1999cited by this paper
• What really happens to people on long-term peritoneal dialysis?

  1998cited by this paper
• In vitro effects of bicarbonate and bicarbonate-lactate buffered peritoneal dialysis solutions on mesothelial and neutrophil function.

  1996cited by this paper
• Are Aldehydes in Heat-Sterllized Peritoneal Dialysis Fluids Toxic in Vitro?

  1995cited by this paper
• Treatment of malnourished CAPD patients with an amino acid based dialysate.

  1995cited by this paper
• Heat Sterilization of Glucose-Containing Fluids for Peritoneal Dialysis: Biological Consequences of Chemical Alterations

  1995cited by this paper
• Peritoneal host defense mechanisms in peritoneal dialysis.

  1994cited by this paper
• Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo.

  1994cited by this paper
• Human peritoneal mesothelial cells synthesize interleukin-8. Synergistic induction by interleukin-1 beta and tumor necrosis factor-alpha.

  1993cited by this paper
• The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.

  1993cited by this paper
• Human peritoneal mesothelial cells synthesize interleukin-6: induction by IL-1 beta and TNF alpha.

  1993cited by this paper
• Human peritoneal mesothelial cells synthesize interleukin-6: Induction by IL-1β and TNFα

  1993cited by this paper
• Mitotic spindle organization by a plus-end-directed microtubule motor

  1992cited by this paper
• Human peritoneal mesothelial cells produce many cytokines (granulocyte colony-stimulating factor [CSF], granulocyte-monocyte-CSF, macrophage-CSF, interleukin-1 [IL-1], and IL-6) and are activated and stimulated to grow by IL-1.

  1992cited by this paper
• Isolation, culture and characterization of human peritoneal mesothelial cells.

  1990cited by this paper
• Cytotoxic Effects of Commercial Continuous Ambulatory Peritoneal Dialysis (CAPD) Fluids and of Bacterial Exoproducts on Human Mesothelial Cells in Vitro

  1989cited by this paper
• Human cdc2 protein kinase is a major cell-cycle regulated tyrosine kinase substrate

  1988cited by this paper
• The effect of dialysate on peritoneal phagocyte oxidative metabolism.

  1988cited by this paper
• Human Peritoneal Mesothelial Cells Produce Many Cytokines (granulocyte Colony-stimulating Factor [csf], Granulocyte-monocyte-csf, Macrophage-csf, Interleukin-1 [il-11, and Il-6) and Are Activated and Stimulated to Grow by Il-1 Peritoneal Mesothelial Cells Proliferated after the Addition of Exogenous

  year unknowncited by this paper

• Differential effects of biocompatible peritoneal dialysis fluids on human mesothelial and endothelial cells in 2D and 3D phenotypes.

  2023cites this paper
• How peritoneal dialysis transforms the peritoneum and vasculature in children with chronic kidney disease—what can we learn for future treatment?

  2022cites this paper
• Understanding Cell Model Characteristics—RNA Expression Profiling in Primary and Immortalized Human Mesothelial Cells, and in Human Vein and Microvascular Endothelial Cells

  2022cites this paper
• Proteome-Wide Differential Effects of Peritoneal Dialysis Fluid Properties in an In Vitro Human Endothelial Cell Model

  2022cites this paper
• Effect of Antioxidant Therapy on Oxidative Stress in Vivo

  2021cites this paper
• Experimental models in peritoneal dialysis (Review)

  2021cites this paper
• A Meta-Analysis of Human Transcriptomics Data in the Context of Peritoneal Dialysis Identifies Novel Receptor-Ligand Interactions as Potential Therapeutic Targets

  2021cites this paper
• Polyphenols Attenuate Highly-Glycosylated Haemoglobin-Induced Damage in Human Peritoneal Mesothelial Cells

  2020cites this paper
• Alpha-1 antitrypsin inhibits formaldehyde-induced apoptosis of human peritoneal mesothelial cells

  2020cites this paper
• Effect of Neutral pH Icodextrin Peritoneal Dialysis Fluid on Mesothelial Cells

  2018cites this paper
• Bicarbonate buffered peritoneal dialysis fluid upregulates angiopoietin-1 and promotes vessel maturation

  2017cites this paper